How to reinvigorate exhausted immune cells to stop cancer How to reinvigorate exhausted immune cells to stop cancer A Penn study has identified a protein called TOX that regulates exhausted T-cells, and could be a key to new immunotherapies.
OncoLink: 25 years—and millions of hits—later OncoLink staff (Photo: Penn Medicine News) OncoLink: 25 years—and millions of hits—later The online source for cancer information turns 25. Last year alone, the website had 4.5 million visits, with half from other countries, and nurses looking for reliable material to educate patients.
Better prognosticating for dogs with mammary tumors Karin Sorenmo (left) and colleagues created a practical tool for assessing prognoses for dogs with mammary tumors. The research emerged from Penn Vet’s Shelter Canine Mammary Tumor Program, which assists in treating and then finding homes for dogs like Brownie, pictured with former oncology intern, Kiley Daube. Better prognosticating for dogs with mammary tumors For dogs with mammary tumors, a course of treatment can depend on a variety of factors, some of which may seem to contradict one another. A new system developed by Penn Vet’s Karin Sorenmo and colleagues can make determining a prognosis and making treatment decisions an easier task.
10-year-old’s cholesterol was over 800. Can CRISPR fix the problem? Penn In the News Philadelphia Inquirer 10-year-old’s cholesterol was over 800. Can CRISPR fix the problem? Kiran Musunuru of the Perelman School of Medicine, who is a partner in a biotech start-up with labs housed at Pennovation Works, spoke about the potential benefits of CRISPR gene-editing for patients with heart disease. A trial for a similar therapy developed by a different team is currently underway at the Abramson Cancer Center. How conquering a rare leukemia in children revolutionized cancer care for millions Penn In the News Philadelphia Inquirer How conquering a rare leukemia in children revolutionized cancer care for millions Carl June of the Perelman School of Medicine was mentioned for his contributions to the field of cancer research. Finding clues to a genetic link to treatment for BRCA1/2 breast cancer patients Finding clues to a genetic link to treatment for BRCA1/2 breast cancer patients New research could shape treatment strategies and clinical trial design for patients with BRCA1 and BRCA2-related breast cancers. Proton therapy side-effects found fewer than conventional radiation The particle accelerator, which sends protons down a beamline as long as a football field through three-story-high gantries, delivers the most cutting-edge proton therapy there is. Proton therapy side-effects found fewer than conventional radiation In the largest study of its kind, Penn researchers compare overall adverse events of proton and photon therapies. Compound’s benefits aren’t tied to the body clock Compound’s benefits aren’t tied to the body clock New research from Penn Medicine overturns what was previously known about a compound associated with reductions in obesity and diabetes risk. Cancer screening rates decline when patients see doctors later in day Cancer screening rates decline when patients see doctors later in day Compared to patients who see their primary care doctor earlier in the day, cancer screening rates decline significantly as the day goes on, according to a new study from researchers in the Perelman School of Medicine and Wharton School. The cancer-body clock connection Disruptions to the circadian rhythm influence tumor growth and cancer treatment. The cancer-body clock connection Researchers at the Perelman School of Medicine show how disruptions to the circadian rhythm influence tumor growth and cancer treatment. Load More
How conquering a rare leukemia in children revolutionized cancer care for millions Penn In the News Philadelphia Inquirer How conquering a rare leukemia in children revolutionized cancer care for millions Carl June of the Perelman School of Medicine was mentioned for his contributions to the field of cancer research. Finding clues to a genetic link to treatment for BRCA1/2 breast cancer patients Finding clues to a genetic link to treatment for BRCA1/2 breast cancer patients New research could shape treatment strategies and clinical trial design for patients with BRCA1 and BRCA2-related breast cancers. Proton therapy side-effects found fewer than conventional radiation The particle accelerator, which sends protons down a beamline as long as a football field through three-story-high gantries, delivers the most cutting-edge proton therapy there is. Proton therapy side-effects found fewer than conventional radiation In the largest study of its kind, Penn researchers compare overall adverse events of proton and photon therapies. Compound’s benefits aren’t tied to the body clock Compound’s benefits aren’t tied to the body clock New research from Penn Medicine overturns what was previously known about a compound associated with reductions in obesity and diabetes risk. Cancer screening rates decline when patients see doctors later in day Cancer screening rates decline when patients see doctors later in day Compared to patients who see their primary care doctor earlier in the day, cancer screening rates decline significantly as the day goes on, according to a new study from researchers in the Perelman School of Medicine and Wharton School. The cancer-body clock connection Disruptions to the circadian rhythm influence tumor growth and cancer treatment. The cancer-body clock connection Researchers at the Perelman School of Medicine show how disruptions to the circadian rhythm influence tumor growth and cancer treatment.
Finding clues to a genetic link to treatment for BRCA1/2 breast cancer patients Finding clues to a genetic link to treatment for BRCA1/2 breast cancer patients New research could shape treatment strategies and clinical trial design for patients with BRCA1 and BRCA2-related breast cancers.
Proton therapy side-effects found fewer than conventional radiation The particle accelerator, which sends protons down a beamline as long as a football field through three-story-high gantries, delivers the most cutting-edge proton therapy there is. Proton therapy side-effects found fewer than conventional radiation In the largest study of its kind, Penn researchers compare overall adverse events of proton and photon therapies.
Compound’s benefits aren’t tied to the body clock Compound’s benefits aren’t tied to the body clock New research from Penn Medicine overturns what was previously known about a compound associated with reductions in obesity and diabetes risk.
Cancer screening rates decline when patients see doctors later in day Cancer screening rates decline when patients see doctors later in day Compared to patients who see their primary care doctor earlier in the day, cancer screening rates decline significantly as the day goes on, according to a new study from researchers in the Perelman School of Medicine and Wharton School.
The cancer-body clock connection Disruptions to the circadian rhythm influence tumor growth and cancer treatment. The cancer-body clock connection Researchers at the Perelman School of Medicine show how disruptions to the circadian rhythm influence tumor growth and cancer treatment.